In last trading session, Minerva Surgical Inc. (NASDAQ:UTRS) saw 0.37 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.18 trading at -$0.01 or -5.95% at ring of the bell on the day assigns it a market valuation of $4.90M. That closing price of UTRS’s stock is at a discount of -4116.67% from its 52-week high price of $7.59 and from its 52-week low price of $0.18. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.38 million shares which gives us an average trading volume of 151.38K if we extend that period to 3-months.
Minerva Surgical Inc. (NASDAQ:UTRS) trade information
Upright in the red during last session for losing -5.95%, in the last five days UTRS remained trading in the red while hitting it’s week-highest on Friday, 11/18/22 when the stock touched $0.18 price level, adding 23.4% to its value on the day. Minerva Surgical Inc.’s shares saw a change of -96.53% in year-to-date performance and have moved -17.93% in past 5-day. Minerva Surgical Inc. (NASDAQ:UTRS) showed a performance of -51.77% in past 30-days. Number of shares sold short was 0.1 million shares which calculate 1.5 days to cover the short interests.
Minerva Surgical Inc. (UTRS) estimates and forecasts
Statistics highlight that Minerva Surgical Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -92.86% of value to its shares in past 6 months, showing an annual growth rate of 60.78% while that of industry is 3.10. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to decrease by -105.70% in the current quarter and calculating -7.70% decrease in the next quarter. This year revenue growth is estimated to fall -2.40% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $12.6 million for the same. And 3 analysts are in estimates of company making revenue of $15.9 million in the next quarter that will end on Dec 2022. Company posted $12.51 million and $13.64 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 0.80% while estimating it to be 16.50% for the next quarter.
Minerva Surgical Inc. is more likely to be releasing its next quarterly report on November 09 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Minerva Surgical Inc. (NASDAQ:UTRS)’s Major holders
Insiders are in possession of 7.36% of company’s total shares while institution are holding 77.38 percent of that, with stock having share float percentage of 83.53%. Investors also watch the number of corporate investors in a company very closely, which is 77.38% institutions for Minerva Surgical Inc. that are currently holding shares of the company. NEA Management Company, LLC is the top institutional holder at UTRS for having 10.0 million shares of worth $23.5 million. And as of Jun 29, 2022, it was holding 34.66% of the company’s outstanding shares.
The second largest institutional holder is Vivo Capital, LLC, which was holding about 2.22 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 7.68% of outstanding shares, having a total worth of $5.21 million.
On the other hand, Fidelity Small Cap Growth Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jul 30, 2022, the former fund manager was holding 0.53 million shares of worth $1.38 million or 1.83% of the total outstanding shares. The later fund manager was in possession of 0.36 million shares on Jun 29, 2022, making its stake of worth around $0.84 million in the company or a holder of 1.23% of company’s stock.